longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

BioKangtai

300601

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 158.04, above the reasonable range, cheaper than 11.11% of the time in the past 5 years, and the industry ranks 38/85, the industry Median 11.73.

158.04xP/E
¥11.77Stock price
¥0.07Earnings per share
158.04xP/E
Stock price¥11.77Earnings per share¥0.07

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
44.09x
Typical range
22.86x–100.38x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 11.73x
04080120160

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 11.73x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
688796SHBiocytogen
154.43x--¥56.57B
300601SZBioKangtai
158.04x75.83%¥13.15B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.